nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—urine—schizophrenia	0.109	0.328	CbGeAlD
Ximelagatran—F2—blood plasma—schizophrenia	0.0571	0.171	CbGeAlD
Ximelagatran—CYP2C9—urine—schizophrenia	0.0436	0.131	CbGeAlD
Ximelagatran—CYP2C9—blood plasma—schizophrenia	0.0227	0.0682	CbGeAlD
Ximelagatran—F2—blood—schizophrenia	0.0209	0.0627	CbGeAlD
Ximelagatran—F2—endocrine gland—schizophrenia	0.0181	0.0544	CbGeAlD
Ximelagatran—F2—nervous system—schizophrenia	0.017	0.0509	CbGeAlD
Ximelagatran—F2—central nervous system—schizophrenia	0.0163	0.049	CbGeAlD
Ximelagatran—F2—brain—schizophrenia	0.013	0.0389	CbGeAlD
Ximelagatran—CYP2C9—blood—schizophrenia	0.00833	0.025	CbGeAlD
Ximelagatran—CYP2C9—endocrine gland—schizophrenia	0.00723	0.0217	CbGeAlD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.00238	0.00357	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.00235	0.00353	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.00232	0.00348	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.0023	0.00346	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CHRM1—schizophrenia	0.00222	0.00333	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—schizophrenia	0.00221	0.00332	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—schizophrenia	0.00217	0.00326	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAG—schizophrenia	0.00217	0.00326	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.00215	0.00323	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DGKI—schizophrenia	0.00213	0.00319	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.00213	0.00319	CbGpPWpGaD
Ximelagatran—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.0021	0.00315	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—AKT1—schizophrenia	0.00209	0.00314	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.00208	0.00312	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.00208	0.00312	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—GRM5—schizophrenia	0.00206	0.0031	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.002	0.003	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00197	0.00295	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL1B—schizophrenia	0.00194	0.00291	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL3RA—schizophrenia	0.00193	0.0029	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DGKI—schizophrenia	0.00193	0.0029	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00193	0.0029	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00193	0.0029	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MAN2A1—schizophrenia	0.00191	0.00287	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.00191	0.00286	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCK—schizophrenia	0.00189	0.00283	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PLA2G4A—schizophrenia	0.00189	0.00283	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP26B1—schizophrenia	0.00187	0.00281	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00187	0.00281	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP26B1—schizophrenia	0.00185	0.00277	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—DPP4—schizophrenia	0.00184	0.00276	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—schizophrenia	0.00182	0.00273	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.00182	0.00272	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCKAR—schizophrenia	0.00181	0.00272	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—HTR2A—schizophrenia	0.00179	0.00268	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—schizophrenia	0.00177	0.00266	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PLA2G4A—schizophrenia	0.00177	0.00265	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PPP1R1B—schizophrenia	0.00177	0.00265	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—ADORA2A—schizophrenia	0.00175	0.00263	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00173	0.0026	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	0.00172	0.00259	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GRM2—schizophrenia	0.0017	0.00255	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—TAAR6—schizophrenia	0.0017	0.00255	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.00169	0.00254	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.00169	0.00254	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GCLM—schizophrenia	0.00167	0.00251	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—YWHAZ—schizophrenia	0.00166	0.00249	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—schizophrenia	0.00164	0.00247	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—FZD3—schizophrenia	0.00164	0.00247	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—NPY—schizophrenia	0.00164	0.00246	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	0.0016	0.0024	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR1B—schizophrenia	0.00158	0.00237	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—OXT—schizophrenia	0.00158	0.00237	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—NGEF—schizophrenia	0.00157	0.00236	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—schizophrenia	0.00156	0.00234	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PPP3CC—schizophrenia	0.00154	0.00232	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GRM2—schizophrenia	0.00154	0.00232	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—TAAR6—schizophrenia	0.00154	0.00232	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—NTS—schizophrenia	0.00154	0.00231	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR1A—schizophrenia	0.00152	0.00228	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—FGA—schizophrenia	0.0015	0.00226	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—NPS—schizophrenia	0.0015	0.00225	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR2C—schizophrenia	0.00147	0.00221	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—DRD1—schizophrenia	0.00147	0.00221	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ATP2A2—schizophrenia	0.00147	0.0022	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—RGS4—schizophrenia	0.00145	0.00217	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GRM3—schizophrenia	0.00145	0.00217	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—APOA1—schizophrenia	0.00144	0.00216	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.00143	0.00215	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NGEF—schizophrenia	0.00143	0.00215	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—DRD3—schizophrenia	0.00142	0.00214	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR6—schizophrenia	0.00142	0.00213	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—schizophrenia	0.00141	0.00211	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NTS—schizophrenia	0.0014	0.0021	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—DRD4—schizophrenia	0.00138	0.00207	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CNR1—schizophrenia	0.00132	0.00198	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—RGS4—schizophrenia	0.00131	0.00197	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GRM3—schizophrenia	0.00131	0.00197	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR6—schizophrenia	0.00129	0.00194	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—DRD2—schizophrenia	0.00129	0.00193	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR7—schizophrenia	0.00129	0.00193	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CHRM1—schizophrenia	0.00125	0.00188	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL3RA—schizophrenia	0.00122	0.00183	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.00118	0.00178	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS1—schizophrenia	0.00117	0.00176	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GRM5—schizophrenia	0.00117	0.00175	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DGKI—schizophrenia	0.00114	0.00171	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CHRM1—schizophrenia	0.00114	0.00171	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL3RA—schizophrenia	0.00111	0.00167	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCK—schizophrenia	0.00107	0.0016	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GRM5—schizophrenia	0.00106	0.00159	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PPP1R1B—schizophrenia	0.00104	0.00157	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PDE4B—schizophrenia	0.00104	0.00156	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCKAR—schizophrenia	0.00102	0.00153	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP2D6—schizophrenia	0.00101	0.00152	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP2D6—schizophrenia	0.000998	0.0015	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ACSL6—schizophrenia	0.000996	0.00149	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SLC27A5—schizophrenia	0.000996	0.00149	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—ADORA2A—schizophrenia	0.000991	0.00149	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FZD3—schizophrenia	0.000971	0.00146	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCK—schizophrenia	0.000968	0.00145	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ACE—schizophrenia	0.000949	0.00143	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PDE4B—schizophrenia	0.000944	0.00142	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCKAR—schizophrenia	0.000928	0.00139	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—NPY—schizophrenia	0.000926	0.00139	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP1A2—schizophrenia	0.000915	0.00137	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FES—schizophrenia	0.000913	0.00137	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PPP3CC—schizophrenia	0.000913	0.00137	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRM2—schizophrenia	0.000913	0.00137	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TAAR6—schizophrenia	0.000913	0.00137	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLA2G4A—schizophrenia	0.000911	0.00137	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP1A2—schizophrenia	0.000903	0.00136	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR2A—schizophrenia	0.000902	0.00135	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ADORA2A—schizophrenia	0.0009	0.00135	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—OXT—schizophrenia	0.000894	0.00134	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR1B—schizophrenia	0.000894	0.00134	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR1A—schizophrenia	0.00086	0.00129	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—YWHAZ—schizophrenia	0.000857	0.00129	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—NPS—schizophrenia	0.000847	0.00127	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NGEF—schizophrenia	0.000844	0.00127	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NPY—schizophrenia	0.000841	0.00126	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DRD1—schizophrenia	0.000831	0.00125	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR2C—schizophrenia	0.000831	0.00125	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NTS—schizophrenia	0.000825	0.00124	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—OXT—schizophrenia	0.000811	0.00122	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR1B—schizophrenia	0.000811	0.00122	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DRD3—schizophrenia	0.000805	0.00121	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	0.000796	0.00119	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR1A—schizophrenia	0.000781	0.00117	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DRD4—schizophrenia	0.000781	0.00117	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RTN4—schizophrenia	0.000776	0.00116	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRM3—schizophrenia	0.000776	0.00116	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RGS4—schizophrenia	0.000776	0.00116	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NPS—schizophrenia	0.000769	0.00115	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—COMT—schizophrenia	0.000767	0.00115	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTP1—schizophrenia	0.000763	0.00115	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—MAOA—schizophrenia	0.000762	0.00114	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR6—schizophrenia	0.000762	0.00114	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—COMT—schizophrenia	0.000757	0.00114	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DRD1—schizophrenia	0.000754	0.00113	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR2C—schizophrenia	0.000754	0.00113	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTP1—schizophrenia	0.000753	0.00113	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CNR1—schizophrenia	0.000746	0.00112	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—APOA1—schizophrenia	0.000741	0.00111	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAG—schizophrenia	0.000736	0.0011	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DRD3—schizophrenia	0.000731	0.0011	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR7—schizophrenia	0.000728	0.00109	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DRD2—schizophrenia	0.000728	0.00109	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DRD4—schizophrenia	0.000709	0.00106	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTM1—schizophrenia	0.000702	0.00105	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTM1—schizophrenia	0.000692	0.00104	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CNR1—schizophrenia	0.000677	0.00102	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CHRM1—schizophrenia	0.000673	0.00101	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR7—schizophrenia	0.000661	0.000992	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DRD2—schizophrenia	0.000661	0.000992	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PRODH—schizophrenia	0.000656	0.000985	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL3RA—schizophrenia	0.000656	0.000984	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NRG3—schizophrenia	0.00064	0.000961	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TLE1—schizophrenia	0.00064	0.000961	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GFAP—schizophrenia	0.000633	0.000949	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRM5—schizophrenia	0.000625	0.000939	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TLE3—schizophrenia	0.000606	0.000909	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	0.000603	0.000905	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCK—schizophrenia	0.000572	0.000859	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PDE4B—schizophrenia	0.000557	0.000837	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCKAR—schizophrenia	0.000548	0.000823	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MPC2—schizophrenia	0.000535	0.000803	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADORA2A—schizophrenia	0.000532	0.000798	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PLA2G4A—schizophrenia	0.000523	0.000785	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGA—schizophrenia	0.00051	0.000765	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR2A—schizophrenia	0.00051	0.000765	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—schizophrenia	0.000501	0.000752	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.000499	0.000749	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLCH2—schizophrenia	0.000497	0.000747	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH4—schizophrenia	0.000497	0.000746	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NPY—schizophrenia	0.000497	0.000746	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ATP2A2—schizophrenia	0.000497	0.000746	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—OXT—schizophrenia	0.000479	0.00072	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR1B—schizophrenia	0.000479	0.00072	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NDST3—schizophrenia	0.000468	0.000702	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR2A—schizophrenia	0.000463	0.000695	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR1A—schizophrenia	0.000461	0.000693	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NPS—schizophrenia	0.000454	0.000682	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR2C—schizophrenia	0.000446	0.000669	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DRD1—schizophrenia	0.000446	0.000669	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC27A5—schizophrenia	0.000443	0.000666	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ACSL6—schizophrenia	0.000443	0.000666	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NTRK2—schizophrenia	0.000434	0.000651	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.000433	0.00065	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DRD3—schizophrenia	0.000432	0.000648	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—EP300—schizophrenia	0.000427	0.000641	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—DAO—schizophrenia	0.000423	0.000635	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DRD4—schizophrenia	0.000419	0.000629	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PNP—schizophrenia	0.000406	0.000609	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CNR1—schizophrenia	0.0004	0.000601	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DRD2—schizophrenia	0.00039	0.000586	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR7—schizophrenia	0.00039	0.000586	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NDUFV2—schizophrenia	0.000377	0.000566	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRL—schizophrenia	0.000369	0.000553	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIP4K2A—schizophrenia	0.000354	0.000532	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.000352	0.000528	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—S100B—schizophrenia	0.000344	0.000516	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB4—schizophrenia	0.000329	0.000493	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP26B1—schizophrenia	0.000321	0.000481	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PLA2G4A—schizophrenia	0.000309	0.000464	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—schizophrenia	0.000306	0.000459	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NRG1—schizophrenia	0.000303	0.000455	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MEF2C—schizophrenia	0.0003	0.000451	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—YWHAZ—schizophrenia	0.00029	0.000436	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TPH1—schizophrenia	0.000286	0.000429	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GCLM—schizophrenia	0.000286	0.000429	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB3—schizophrenia	0.000284	0.000426	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR2A—schizophrenia	0.000273	0.00041	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000269	0.000404	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PRKD1—schizophrenia	0.000269	0.000403	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—schizophrenia	0.000258	0.000388	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOE—schizophrenia	0.000254	0.000381	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOA1—schizophrenia	0.000251	0.000377	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ESR1—schizophrenia	0.000243	0.000364	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GAPDH—schizophrenia	0.000224	0.000337	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CLOCK—schizophrenia	0.000222	0.000334	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000222	0.000333	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GSK3B—schizophrenia	0.00022	0.00033	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000219	0.000329	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TPH2—schizophrenia	0.000217	0.000325	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CACNB2—schizophrenia	0.000217	0.000325	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—DPYD—schizophrenia	0.000213	0.00032	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CACNA1C—schizophrenia	0.000198	0.000297	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3C2A—schizophrenia	0.000193	0.00029	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2D6—schizophrenia	0.000173	0.00026	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SNAP25—schizophrenia	0.000173	0.00026	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—schizophrenia	0.000163	0.000245	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1A2—schizophrenia	0.000157	0.000235	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TH—schizophrenia	0.000154	0.000232	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—schizophrenia	0.000148	0.000222	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EP300—schizophrenia	0.000145	0.000217	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—COMT—schizophrenia	0.000131	0.000197	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTP1—schizophrenia	0.000131	0.000196	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MAOA—schizophrenia	0.00013	0.000196	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000126	0.00019	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCB1—schizophrenia	0.000124	0.000186	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—schizophrenia	0.00012	0.00018	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLA2G4A—schizophrenia	0.00012	0.00018	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—schizophrenia	0.000106	0.000159	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—schizophrenia	0.000104	0.000156	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOE—schizophrenia	9.87e-05	0.000148	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOA1—schizophrenia	9.76e-05	0.000146	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—schizophrenia	8.75e-05	0.000131	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—EP300—schizophrenia	5.63e-05	8.44e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—schizophrenia	3.4e-05	5.1e-05	CbGpPWpGaD
